← Back to Search

Behavioural Intervention

Experimental feedback for Opioid Use Disorder

N/A
Waitlist Available
Led By Kathleen Garrison, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to one month post follow-up.
Awards & highlights

Study Summary

This trial is testing whether training people with opioid use disorder to control their brain activity can help reduce symptoms.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to one month post follow-up (up to 2 months).
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to one month post follow-up (up to 2 months). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid use
Secondary outcome measures
2. Functional connectivity patterns in the brain
Negative affect
Opioid Craving

Trial Design

2Treatment groups
Experimental Treatment
Group I: NeurofeedbackExperimental Treatment1 Intervention
Three imaging (fMRI) sessions of experimental feedback.
Group II: Control feedbackExperimental Treatment1 Intervention
Three imaging (fMRI) sessions of control feedback.

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,863 Previous Clinical Trials
2,742,569 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,485 Previous Clinical Trials
2,622,368 Total Patients Enrolled
Kathleen Garrison, PhDPrincipal InvestigatorYale University
~3 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top